Analysis and Commentary Guest User 4/16/21 Analysis and Commentary Guest User 4/16/21 Highlights from the Past Week Read More Advocacy at a Glance Guest User 4/16/21 Advocacy at a Glance Guest User 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More Guest User 4/12/21 Guest User 4/12/21 President's Budget Preview for FY 22 Read More Advocacy at a Glance Guest User 4/9/21 Advocacy at a Glance Guest User 4/9/21 Getting a Firm Grasp on the Budget Preview Read More Advocacy at a Glance Guest User 4/9/21 Advocacy at a Glance Guest User 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More Analysis and Commentary Guest User 4/3/21 Analysis and Commentary Guest User 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More Advocacy at a Glance Guest User 4/3/21 Advocacy at a Glance Guest User 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More Analysis and Commentary Guest User 3/27/21 Analysis and Commentary Guest User 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More Advocacy at a Glance Guest User 3/27/21 Advocacy at a Glance Guest User 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More Analysis and Commentary Guest User 3/19/21 Analysis and Commentary Guest User 3/19/21 Two Topical Political Issues Read More Advocacy at a Glance Guest User 3/19/21 Advocacy at a Glance Guest User 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More Guest User 3/19/21 Guest User 3/19/21 Alliance Statement on Confirmation of HHS Secretary Becerra Read More Analysis and Commentary Guest User 3/13/21 Analysis and Commentary Guest User 3/13/21 DMAP: Focusing on a Fundamental Challenge Read More Advocacy at a Glance Guest User 3/13/21 Advocacy at a Glance Guest User 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More Analysis and Commentary Guest User 3/6/21 Analysis and Commentary Guest User 3/6/21 Critical Supply Chains and the FDA Read More Advocacy at a Glance Guest User 3/6/21 Advocacy at a Glance Guest User 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More Analysis and Commentary Guest User 2/27/21 Analysis and Commentary Guest User 2/27/21 Questions (and Answers) About Current Political Issues Read More Advocacy at a Glance Guest User 2/28/21 Advocacy at a Glance Guest User 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More Analysis and Commentary Guest User 2/19/21 Analysis and Commentary Guest User 2/19/21 "FDA Exceptionalism," Redux (Again) Read More Advocacy at a Glance Guest User 2/19/21 Advocacy at a Glance Guest User 2/19/21 Senator Tammy Baldwin is the new Chairwoman of the Senate Ag/FDA appropriations subcommittee. Reconciliation is advancing and includes $500 million to support FDA’s COVID activities. Read More Newer Posts Older Posts
Analysis and Commentary Guest User 4/16/21 Analysis and Commentary Guest User 4/16/21 Highlights from the Past Week Read More
Advocacy at a Glance Guest User 4/16/21 Advocacy at a Glance Guest User 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More
Advocacy at a Glance Guest User 4/9/21 Advocacy at a Glance Guest User 4/9/21 Getting a Firm Grasp on the Budget Preview Read More
Advocacy at a Glance Guest User 4/9/21 Advocacy at a Glance Guest User 4/9/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. A preview of President Biden’s Budget Request will be released on April 9. Read More
Analysis and Commentary Guest User 4/3/21 Analysis and Commentary Guest User 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More
Advocacy at a Glance Guest User 4/3/21 Advocacy at a Glance Guest User 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Analysis and Commentary Guest User 3/27/21 Analysis and Commentary Guest User 3/27/21 Alliance Working Hard on BA Appropriation for FY 22 Read More
Advocacy at a Glance Guest User 3/27/21 Advocacy at a Glance Guest User 3/27/21 OMB will provide a preview of the President’s FY 22 Budget Request next week. CBER releases its five-year strategic plan. Read More
Analysis and Commentary Guest User 3/19/21 Analysis and Commentary Guest User 3/19/21 Two Topical Political Issues Read More
Advocacy at a Glance Guest User 3/19/21 Advocacy at a Glance Guest User 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More
Guest User 3/19/21 Guest User 3/19/21 Alliance Statement on Confirmation of HHS Secretary Becerra Read More
Analysis and Commentary Guest User 3/13/21 Analysis and Commentary Guest User 3/13/21 DMAP: Focusing on a Fundamental Challenge Read More
Advocacy at a Glance Guest User 3/13/21 Advocacy at a Glance Guest User 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More
Analysis and Commentary Guest User 3/6/21 Analysis and Commentary Guest User 3/6/21 Critical Supply Chains and the FDA Read More
Advocacy at a Glance Guest User 3/6/21 Advocacy at a Glance Guest User 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More
Analysis and Commentary Guest User 2/27/21 Analysis and Commentary Guest User 2/27/21 Questions (and Answers) About Current Political Issues Read More
Advocacy at a Glance Guest User 2/28/21 Advocacy at a Glance Guest User 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More
Analysis and Commentary Guest User 2/19/21 Analysis and Commentary Guest User 2/19/21 "FDA Exceptionalism," Redux (Again) Read More
Advocacy at a Glance Guest User 2/19/21 Advocacy at a Glance Guest User 2/19/21 Senator Tammy Baldwin is the new Chairwoman of the Senate Ag/FDA appropriations subcommittee. Reconciliation is advancing and includes $500 million to support FDA’s COVID activities. Read More
